Rinostop Nazal drop. 0.05% 10ml vial, cap. pl.

$0.81

Rinostop Nazal drop. 0.05% 10ml vial, cap. pl.

Quantity:

SKU: 1233103837 Categories: , , Tags: ,

Description

Composition
Active substance:
1 mL contains: xylometazoline hydrochloride – 0.50 mg or 1.00 mg ;.
Excipients:
Disodium edetate (Trilon B), sodium chloride, benzalkonium chloride, potassium dihydrogenphosphate, disodium hydrogenphosphate dodecahydrate, purified water.
Description:
Clear, colorless or slightly brownish liquid.
Product form:
Nasal drops, 0.05% and 0.1%.
10 ml or 15 ml vials dropper polymer to control the first opening. 1 Dropper bottle polymer together with instructions for use in a stack of cardboard.
Contraindications
Hypersensitivity to Xylometazoline, hypertension, tachycardia, expressed atherosclerosis, glaucoma, atrophic rhinitis, thyrotoxicosis, surgical interventions in the meninges (history), the state after transsphenoidal hypophysectomy, pregnancy, infancy (up to 2 years – to 0.05 % solution, aged 6 – for 0.1% solution).
Do not use in the therapy of monoamine oxidase inhibitors and tricyclic antidepressants or tetracyclic antidepressants, including 14 days after their removal, as well as other drugs that increase blood pressure.
Precautions: diabetes mellitus, ischemic heart disease (angina), prostatic hyperplasia, pheochromocytoma, porphyria, hyperthyroidism, lactation, patients with hypersensitivity to adrenergic drugs, accompanied by insomnia, dizziness, arrhythmia, tremor, increased blood pressure.
Dosage
0.5 mg / ml
Indications
Applied with acute respiratory diseases with symptoms of rhinitis (common cold), acute allergic rhinitis, sinusitis, otitis media with (in combination therapy to reduce the swelling of the mucosa of the nasopharynx).
Preparing the patient for diagnostic procedures in the nasal passages.
Interaction with other drugs
Perhaps increased systemic action while applying monoamine oxidase inhibitors, and tricyclic antidepressants.
Overdose
In overdose or accidentally taking the drug inside may develop following symptoms: nausea, vomiting, cyanosis, fever, tachycardia, arrhythmia, increased blood pressure, dizziness, mental disorders, depression of the central nervous system (drowsiness, reduction of body temperature, bradycardia, decrease in blood pressure, breathing and coma stop).
Treatment: symptomatic: Accidental ingestion – gastric lavage, activated charcoal.
pharmachologic effect
Pharmacological group:
Decongestant agent – alpha-agonists.
Pharmacological properties:
Xylometazoline refers to a group of local vasoconstrictive agents (decongestants) with alpha-Adrenomimeticalkie activity causes vasoconstriction of nasal mucosa, thereby eliminating, edema and hyperemia of the nasal mucosa, nasal restores patency, easier nasal breathing.
Effect of the drug occurs within a few minutes after its application and continues until 10 hours.
Pharmacokinetics:
When applied topically, the drug is practically not absorbed, however, its concentration in the blood plasma is very low (modern analytical methods not determined).
Pregnancy and breast-feeding
During pregnancy, the use of the drug is contraindicated.
During lactation the drug should be used only on prescription, after a careful assessment of risks and benefits for mother and child. It is not allowed to exceed the recommended dosage.
Conditions of supply of pharmacies
Without recipe.
side effects
The incidence of adverse events is estimated as follows: very common:> 1/10; common:> 1/100 and
special instructions
nasal passages should be cleaned before use.
It should not be used for a long time, for example, in chronic rhinitis.
Do not exceed the recommended dose and increase the duration of treatment.
The effect on the ability to operate vehicles, machinery
In compliance with the dosing regimen ksilometazolin no effect on sustaining attention and concentration-tion. At doses greater than recommended, the drug may affect the ability to drive vehicles or machinery.
Storage conditions
At a temperature of 2 to 25 C.
Keep out of the reach of children.
Dosing and Administration
Adults and children over 6 years of age are administered by 1-2 drops of 0.1% xylometazoline solution into each nasal passage 2-3 times a day.
Children from 2 to 6% solution was used 0.05 1-2 drops into each nostril 1-2 times a day.
Do not use the drug without interruption for more than 3-5 days.
Information
Appearance may differ from that depicted in the picture. There are contraindications. You need to read the manual or consult with a specialist

Additional information

Weight0.100 kg
Manufacturer

OTISIFARM

There are no reviews yet.

Add your review